WEGO Corporate and Strategy Overview slide image

WEGO Corporate and Strategy Overview

Innovation and talents strategies WEGO thrives to accelerate future development embracing new opportunities, pushing boundaries of innovation, expanding in-house R&D investment, and gathering top talents Iteration of existing product offerings Improving the existing products and investing in further R&D in line with the product line strategy Upgrading the existing products to improve functionality, utilizing new materials, and lowering production costs Boosting R&D investment In 2022, the Company has invested RMB 550mm in R&D, posting an increase of 9% compared to the previous year. Meantime, WEGO's R&D team has continued to expand In 2022, the Company obtained 123 new patents, had 171 patents under application and received 60 new product registration certificates WEGO威高 Innovation strategy Personnel strategy Attracting top talents Attracting top talents from around the world, including senior executives from multinational corporations The sub-headquarter in Shanghai offers a strategic location that enables the Company to bring together more talents The talented team not only supports the development of the exiting business segments, but also enables the Company to explore new business opportunities and revenue streams Strategic planning for new products Established R&D centers in Shanghai and Suzhou, focusing on tackling key technological challenges and developing major breakthrough products Aim to expand the product portfolio through domestic and international M&As, driving innovation and bringing new solutions to the market, including infusion port products, integrated sports medicine solutions, and precision medical products Investing in potential new ventures WEGO is committed to staying ahead of industry trends, proactively making strategic investments and acquisitions to drive growth and expand the business In recent years, the Company has invested in four domestic and international healthcare focused funds with a total size of RMB 3.3bn, tapping into a diverse range of fields including medical aesthetics, orthopedics, robotics, rehabilitation, and medical materials 12
View entire presentation